Guillon J, Charbonnel B
Diabete Metab. 1975 Sep;1(3):191-9.
Diabetes mellitus is more frequently found in pateints with hepatic cirrhosis (about 10%) than in subjects without liver disease. Cirrhosis has been the main subject of interest in this respect. Very few studies have been made in viral hepatitis or steatosis. In about 40% of cases, the diabetes is identified before the cirrhosis. More often (in about 60% of cases) the diabetes is discovered at the same time as or after the finding of cirrhosis. This "post-cirrhosis diabetes" shows no clinical peculiarity. In about 80% of patients with liver cirrhosis when fasting blood glucose is normal, abnormalities of carbohydrate metabolism are to be found by the oral glucose tolerance test. Approximately 50% show an abnormal response to intravenous glucose and 30% to intravenous tolbutamide. The "mechanism" of these metabolic abnormalities in liver cirrhosis is unknown. The following abnormalities are observed: 1) With similar glycaemic response to a glucose challenge, plasma insulin levels are higher than in patients without liver disease, suggesting insulin unresponsiveness. Resistance to exogenous insulin can be demonstrated. 2) Plasma free fatty acid levels are often elevated. 3) Plasma growth hormone levels are often raised. 4) Plasma glucagon levels are high when porto-caval shunting is present. 5) Potassium is often depleted. These metabolic abnormalities, in association with porto-caval shunting and hepatocyte insufficiency may explain the insulin resistance which characterises liver cirrhosis, and the diabetes which it may precipitate in predisposed persons.
肝硬化患者中糖尿病的发病率(约10%)高于无肝脏疾病的人群。在这方面,肝硬化一直是主要的研究对象。关于病毒性肝炎或脂肪变性的研究很少。约40%的病例中,糖尿病在肝硬化之前被确诊。更常见的情况(约60%的病例)是糖尿病在发现肝硬化的同时或之后被发现。这种“肝硬化后糖尿病”没有临床特异性。在约80%的肝硬化患者中,空腹血糖正常时,口服葡萄糖耐量试验可发现碳水化合物代谢异常。约50%的患者对静脉注射葡萄糖反应异常,30%对静脉注射甲苯磺丁脲反应异常。肝硬化中这些代谢异常的“机制”尚不清楚。观察到以下异常情况:1)在对葡萄糖刺激有相似血糖反应的情况下,肝硬化患者的血浆胰岛素水平高于无肝脏疾病的患者,提示胰岛素无反应性。对外源性胰岛素的抵抗可以得到证实。2)血浆游离脂肪酸水平常升高。3)血浆生长激素水平常升高。4)存在门腔分流时,血浆胰高血糖素水平升高。5)钾常缺乏。这些代谢异常,与门腔分流和肝细胞功能不全相关,可能解释了肝硬化特有的胰岛素抵抗以及在易感人群中可能引发的糖尿病。